News for Healthier Living
A Nuclear Target to Revive Anti-Tumor Immunity
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A--all-trans retinoic acid--compromises both the body's normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine.
January 5, 2026
January 6 2026January 5 2026January 4 2026January 3 2026January 2 2026January 1 2026December 31 2025December 30 2025December 29 2025December 28 2025December 27 2025December 26 2025December 24 2025
|
|
|
|
|